Corteva, the Basic Materials sector company, was revisited by a Wall Street analyst today. Analyst Joshua Spector from UBS downgraded the rating on the stock to a Hold and gave it a $80.00 price target.
Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Joshua Spector has given his Hold rating due to a combination of factors, chiefly that Corteva’s share price has risen close to his target, leaving a more balanced mix of upside and downside. He also sees the planned separation of the Seed and Crop Protection units as introducing execution and structural risks, particularly around potential dis-synergies, cost changes, and the resilience of standalone Crop Chemicals volumes and pricing.
At the same time, he views the Seed division as a strong, higher‑growth asset that could warrant a better valuation over time, supported by solid historical EBITDA growth and additional licensing income from the Bayer settlement. However, growth being driven more by price/mix than volume, heightened competitive threats in U.S. soy, and an only modestly conservative outlook that caps near‑term re‑rating potential lead him to expect the shares to trade in a range until the spin is completed, justifying a Neutral stance.